| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |